The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

Myopenia-a new universal term for muscle wasting

(2011) Kenneth Fearon et al.   Journal of Cachexia Sarcopenia and Muscle

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

(2010) Thomas Kung et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Ghrelin for cachexia

(2010) Takashi Akamizu et al.   Journal of Cachexia Sarcopenia and Muscle

Pathophysiology and treatment of inflammatory anorexia in chronic disease

(2010) Theodore P. Braun et al.   Journal of Cachexia Sarcopenia and Muscle

Ethical guidelines for authorship and publishing in theJournal of Cachexia, Sarcopenia and Muscle

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia as a major underestimated and unmet medical need: facts and numbers

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer

(2010) Robert D. Kilgour et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION